ArticleWorld journal of gastrointestinal endoscopy2026
Timing of intervention: Assessing early
Article in World journal of gastrointestinal endoscopy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute cholangitis (AC) is characterized by infection and inflammation of the biliary tree, often resulting from acute biliary obstruction.
aimTo evaluate outcomes of endoscopic retrograde cholangiopancreatography (ERCP) and laparoscopic common bile duct exploration (LCBDE) in the management of AC, focusing on timing, complications, and hospital resource utilization.
methodsBetween 2016 and 2021, a total of 31817 patients were included, with 30330 (95.3%) undergoing ERCP and 1487 (4.67%) undergoing LCBDE.
resultsERCP patients were older (mean age 64.5 years
conclusionERCP remains the preferred intervention for AC, with earlier procedures resulting in better outcomes and lower resource utilization. LCBDE, while less common, is associated with longer hospital stays and higher costs, particularly when performed late. Optimizing timing for both ERCP and LCBDE is critical to improving patient outcomes and reducing healthcare expenditures.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.